139 related articles for article (PubMed ID: 8165016)
1. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors.
Ng HK; Lo SY; Huang DP; Poon WS
Pathology; 1994 Jan; 26(1):1-5. PubMed ID: 8165016
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and p53 expression in human gliomas.
Sipos L; Szegedi Z; Fedorcsák I; Afra D; Szende B
Pathol Oncol Res; 1998; 4(4):267-70. PubMed ID: 9887356
[TBL] [Abstract][Full Text] [Related]
3. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of p53 in human gliomas.
Bruner JM; Saya H; Moser RP
Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
[TBL] [Abstract][Full Text] [Related]
5. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
7. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
[TBL] [Abstract][Full Text] [Related]
8. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
Karamitopoulou E; Perentes E; Diamantis I
Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
[TBL] [Abstract][Full Text] [Related]
9. Expression of the p53 protein in a spectrum of astrocytic tumours.
Ellison DW; Gatter KC; Steart PV; Lane DP; Weller RO
J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
[TBL] [Abstract][Full Text] [Related]
10. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
11. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
Suren D; Isiksacan Ozen O
J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
[TBL] [Abstract][Full Text] [Related]
12. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.
Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW
J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095
[TBL] [Abstract][Full Text] [Related]
14. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
Fults D; Pedone C
Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of p53 gene and protein alterations in human astrocytic tumors.
Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR
J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]